Brief: AB Science Announces Drawdown Of Second Tranche Of EUR 6 Mln
31/01/2023 17:27
Jan 31 (Reuters) - AB Science SA ABS.PA :
* AB SCIENCE ANNOUNCES THE DRAWDOWN OF THE SECOND TRANCHE OF
6
MILLION EUROS UNDER ITS FINANCING AGREEMENT WITH THE EUROPEAN
INVESTMENT BANK
Source text for Eikon: ID:nGNX4kSsC2
Further company coverage: ABS.PA
(Reporting by Gdansk newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on AB Science SA
See all newsBrief: AB Science Expects To Resume AB8939 Phase 1 In Q1 2027 And Masitinib Phase 3 In Q4 2027
Brief: AB Science Discontinues Phase 2 AB20006, Phase 3 AB15003, Phase 3 AB20009 Studies
Brief: AB Science Temporarily Halts Europe Clinical Trials Ahead Of Strategic Reorganization
Brief: AB Science Says FDA Granted Status Of Minor Use In Major Species For Masivet
Brief: AB Science Says Co Received Japanese Patent Protection To Use Masitinib In Progressive MS Until 2041